ACC.26 Día 1 (Parte 1)
Sobre este episodio
En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este primer día en el ACC 2026 de Nueva Orleans. - Effects Of Tirzepatide Compared With Dulaglutide On Expanded Cardiorenal Outcomes - Reliability Of CAC=0 To Exclude Coronary Plaque In Diverse Global Cohorts - Outcomes In Patients With Atrial Fibrillation Randomized To Receive Left Atrial Appendage Closure Or Oral Anticoagulation: Primary Results Of The CHAMPION-AF Clinical Trial - Primary Left Ventricular Unloading In Anterior ST-Segment Elevation Myocardial Infarction (STEMI) Without Cardio genic Shock - Kardinal: A Phase 2 Study Of Tonlamarsen For The Treatment Of Uncontrolled Hypertension - Evolocumab In Patients Without Significant Atherosclerosis: Results From VESALIUS-CV